EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study

Dominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, Marjon H Cnossen, Paul L den Exter, Olivier W H van der Heijden, Ilmar C Kruis, Karina Meijer, Marjolein Peters, Roger E G Schutgens, Waander L van Heerde, Laurens Nieuwenhuizen und 2 weitere

Journal of Thrombosis and Haemostasis · 2023

DOI: 10.1016/j.jtha.2023.07.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Dominique P M S M Maas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, th…. Hauptthemen laut MEDLINE: Menorrhagia, Hemorrhagic Disorders, Blood Coagulation Disorders. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heavy menstrual bleeding (HMB) is associated with a reduced quality of life and limitations in social and physical functioning. Data on HMB in women with rare bleeding disorders (RBDs), including coagulation factor deficiencies and fibrinolytic disorders, are scarce. OBJECTIVES: To analyze the prevalence, severity, and treatment of HMB in Dutch women with an RBD. METHODS: The Rare Bleeding Disorders in the Netherlands (RBiN) study included 263 patients with an RBD from all 6 hemophilia treatment centers (October 2017-November 2019). In this analysis, data of 111 women aged ≥16 years were studied. According to the International Society on Thrombosis and Haemostasis bleeding assessment tool, HMB symptoms were scored from 0 (no/trivial) to 4 (severe symptoms requiring medical intervention). HMB was defined as a score ≥1. Age at RBD diagnosis was extracted from patient files. RESULTS: HMB was reported by 80% of women (89/111) and was more prevalent in women with a fibrinolytic disorder (33/35; 94%) than in women with a coagulation factor deficiency (56/76; 74%) (P = .011). Of the 89 women with HMB, 82% (n = 73) ever required treatment. Multiple treatment modalities were frequently used, both in severe and mild deficiencies. Hormonal treatment was mostly used (n = 64; 88%), while antifibrinolytics were prescribed less frequently (n = 18; 25%). In women with HMB since menarche (n = 61; 69%), median age at RBD diagnosis was 28 years (IQR, 14-41). CONCLUSION: HMB is common in women with RBDs. Women with mild deficiencies also frequently reported HMB. Only a minority of women were treated with hemostatic agents. A significant diagnostic delay was observed after the onset of HMB symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MenorrhagiaHemorrhagic DisordersBlood Coagulation DisordersFemaleHumansAdolescentYoung AdultAdultRetrospective StudiesDelayed DiagnosisPrevalenceQuality of LifeNetherlandsBlood Coagulation Factors

Stichwörter der Autor:innen

blood coagulation disorders, inheritedfibrinolysismenorrhagiamenstruationuterine hemorrhage

Substanzen

Blood Coagulation Factors

Autor:innen und Institutionen

  • Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, the Netherlands.
  • Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Netherlands Hemophilia Society, Nijkerk, the Netherlands.

Zitieren

APA

Maas, D. P. M. S. M., Saes, J. L., Blijlevens, N. M. A., Cnossen, M. H., den Exter, P. L., van der Heijden, O. W. H., Kruis, I. C., Meijer, K., Peters, M., Schutgens, R. E. G., van Heerde, W. L., Nieuwenhuizen, L., Schols, S. E. M., & RBiN study group (2023). High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.07.014

Vancouver

Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, van der Heijden OWH, et al. High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.07.014

BibTeX
@article{Maas2023,
  author = {Maas, Dominique P M S M and Saes, Joline L and Blijlevens, Nicole M A and Cnossen, Marjon H and den Exter, Paul L and van der Heijden, Olivier W H and Kruis, Ilmar C and Meijer, Karina and Peters, Marjolein and Schutgens, Roger E G and van Heerde, Waander L and Nieuwenhuizen, Laurens and Schols, Saskia E M and RBiN study group, RBiN study group},
  title = {High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  doi = {10.1016/j.jtha.2023.07.014}
}
Kostenlos starten →